Ningetinib plus gefitinib in EGFR-mutant non-small-cell lung cancer with MET and AXL dysregulations: A phase 1b clinical trial and biomarker analysis
| Autor: | Zhao, Shen, Ma, Yuxiang, Liu, Lianke, Fang, Jian, Ma, Haiqing, Feng, Guosheng, Xie, Bo, Zeng, Shan, Chang, Jianhua, Ren, Jun, Zhang, Yingjun, Xi, Ning, Zhuang, Yulei, Jiang, Yingzhi, Zhang, Qi, Kang, Ning, Zhang, Li, Zhao, Hongyun |
|---|---|
| Zdroj: | In Lung Cancer February 2024 188 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect